Humana Inc

HUM is in a Stage 2 advancing phase with bullish medium- and long-term biases underpinned by rising EMAs and a consistent higher-high/lower-low structure. An active Bullish Exhaustion pattern at new highs, along with extreme overbought conditions, signals waning upside momentum and unfavorable short-term timing. Price is extended above the 9/20/50 EMA cluster, so deferred entry on a pullback into that support zone offers a higher-probability engagement point.

• ↑Q4 2025 revenue $26.8B (+10% YoY) and adjusted EPS $17.14 beat guidance
• ↑AEP added ~1M members (+20% YoY), with 75% from high-lifetime-value channels
• ↓Negative earnings yield and weak profitability hinder return generation